2020 Vascular Grafts Market Report- Angiograft LLC,  Ariste Medical LLC,  Aruga Technologies LLC,  Biosurfaces Inc and more

Vascular Grafts Market
Press Release

ReportsnReports added a new report on The Vascular Grafts Market report delivers the clean elaborated structure of the Report comprising each and every business related information of the market at a global level. The complete range of information related to the Vascular Grafts Market is obtained through various sources and this obtained bulk of the information is arranged, processed, and represented by a group of specialists through the application of different methodological techniques and analytical tools such as SWOT analysis to generate a whole set of trade based study regarding the Vascular Grafts Market.

Download FREE PDF sample of this Report @  https://www.reportsnreports.com/contacts/requestsample.aspx?name=2826481

Vascular Grafts Market Top Companies:
Angiograft LLC
Ariste Medical LLC
Aruga Technologies LLC
Biosurfaces Inc
Cardiojustable LLC (Inactive)

and more…

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vascular Grafts pipeline products.

Scope of this Report:
– Extensive coverage of the Vascular Grafts under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Vascular Grafts and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy this Report:
The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Vascular Grafts under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
– In-depth analysis of the product’s current stage of development, territory and estimated launch date.

Get FLAT 20% Discount on this Report @ https://www.reportsnreports.com/purchase.aspx?name=2826481

Table of Contents in this Report:
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Vascular Grafts Overview 8
3 Products under Development 9
3.1 Vascular Grafts – Pipeline Products by Stage of Development 9
3.2 Vascular Grafts – Pipeline Products by Segment 10
3.3 Vascular Grafts – Pipeline Products by Territory 11
3.4 Vascular Grafts – Pipeline Products by Regulatory Path 12
3.5 Vascular Grafts – Pipeline Products by Estimated Approval Date 13
3.6 Vascular Grafts – Ongoing Clinical Trials 14
4 Vascular Grafts – Pipeline Products under Development by Companies 15
4.1 Vascular Grafts Companies – Pipeline Products by Stage of Development 15
4.2 Vascular Grafts – Pipeline Products by Stage of Development 17
5 Vascular Grafts Companies and Product Overview 19
5.1 Angiograft LLC Company Overview 19
5.1.1 Angiograft LLC Pipeline Products & Ongoing Clinical Trials Overview 19
5.2 Ariste Medical LLC Company Overview 20
5.2.1 Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 20
5.3 Aruga Technologies LLC Company Overview 21
5.3.1 Aruga Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 Biosurfaces Inc Company Overview 22
5.4.1 Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview 22
5.5 Cardiojustable LLC (Inactive) Company Overview 23
5.5.1 Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 23
5.6 Cardiovate Company Overview 24
5.6.1 Cardiovate Pipeline Products & Ongoing Clinical Trials Overview 24
5.7 Colorado Therapeutics, LLC Company Overview 25
5.7.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
5.8 CryoLife Inc Company Overview 26
5.8.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.9 Cytograft Tissue Engineering Inc (Inactive) Company Overview 27
5.9.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 27
5.10 DSM Biomedical BV Company Overview 29
5.10.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 29
5.11 Eqalix Inc Company Overview 30
5.11.1 Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview 30
5.12 FIT Biotech Oy Company Overview 32
5.12.1 FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 32
5.13 Gel-Del Technologies, Inc. Company Overview 34
5.13.1 Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.14 Humacyte Inc Company Overview 35
5.14.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 35
5.15 Innovia LLC Company Overview 41
5.15.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 41
5.16 LeMaitre Vascular Inc Company Overview 42
5.16.1 LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 42
5.17 Merit Medical Systems Inc Company Overview 44
5.17.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 44
5.18 Nationwide Children’s Hospital Company Overview 45
5.18.1 Nationwide Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 45
5.19 Northwestern University Company Overview 46
5.19.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 46
5.20 Peca Labs Inc Company Overview 47
5.20.1 Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 47
6 Vascular Grafts- Recent Developments 64
6.1 Nov 04, 2019: PQ Bypass initiates pivotal study of next-generation advancement in Stent Graft Technology for Treatment of Patients with Peripheral Artery Disease 64
6.2 Oct 30, 2019: CryoLife reports third quarter 2019 financial results 64
6.3 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 65
6.4 Oct 23, 2019: LeMaitre Vascular announces Q3 2019 financial results 67
6.5 Oct 15, 2019: LifeNet Health establishes world’s first dedicated regenerative medicine logistics and distribution center in Indianapolis 68
7 Appendix 88
7.1 Methodology 88

and more..


Ganesh Pardeshi

Close